This one has a nice impulse up and it starting to look like it will continue that move. Once breaking out of the larger degree structure it looks like some positive buying is happening now.
Long swing play. Shown here on the weekly is a bullish falling wedge. Has seen quite the sell off perhaps in a 'sell the news' event following vaccine frenzy. But Pfizer isn't going anywhere.
In December AcelRx published clinical data in „The Journal of Universal Surgery“ titled „A Medication Use Evaluation of Sufentanil Sublingual Tablet 30 mcg for the Perioperative Management of Surgical Pain“. What is DSUVIA? According to AcelRx DSUVIA is a recently approved drug „indicated for use in adults in certified medically supervised healthcare settings for...
#ENLV is in the news last week with regards to Covid-19 treatment. I would be looking at the 18.46 area for a retest, and possible entry if we find support. 100% measured move would take the breakout to 23.81 and ultimately that would be my first target. Id consider this trade still healthy above 15.49 and ultimately any lower than 14.54 i would stop out of a...
Please help me find something wrong about this stock I can't seem to find anything...
Nice Price action on Daily and Weekly, looks like ready to retest the green zone as shown in my analysis. No position YET.
The stock has been in an uptrend and has taken an important support at its trendline in daily chart. It has been confirmed by forming bullish candlestick pattern called hammer at trendline support. One can go long by placing a stoploss of 889 and target can be 990. ( This is posted for education purpose only, Personal due diligence advised)
Buy Case : Increase demand for mental health services COVID indirect impact. New and Innovative way of tackling depression and other mental health disorders and mental issues. Correction from the high and expecting little consolidation around the price points mentioned in the chart Any ideas and comments are welcomed! Thanks in advance! Together, we stand strong!
In Day Time frame, Astra Zeneca was engulfed with a bullish candle and took support perfectly in below resistance. This is my own analysis, if you are going for a trade do your own analysis or consult your Trading advisor.
COHERUS BIOSCIENCES Inc., NASDAQ:CHRS , is a bioscience company that has not yet not benefited from the sector's outperformance despite significantly improving financials and the business becoming profitable. When the stock price cracks the $21 level it will unlock a significant bullish potential.
The chinese love powder made from endangered animals and trash plants , americans love their superfoods. A plant called alfalfa (luzerne) that french farmers love to grow because it can get Nitrogen itself and it's cheap and packed with protein, they feed it to cattle, so to cows and also americans. Americans actually pay a high price to get supercheap leaves in...
Weekly chart outlook for the long term. I see some upside in the near future . Lets see how this plays out. Mainly publishing to come back and study the price action.
FHTX could go for a run after this consolidation. Last time it consolidated for 14 days. We are only on day 8 currently, but it could break higher at anytime. Looks like it ran out of sellers. Could be a good run if it breaks out of this consolidation box.
CXRXF has been consolidating for a long time but now presents a low risk buy in. Notice the two trend lines, we are currently at the lower one. It could drop back 10% but I suspect even if it does, it will eventually drift towards the upper trend line. That's a nice 46% gain from here. Who knows, if it breaks the upper line it could really run.
People have written obituaries about this stock, as it is not moving since March 2020. Stock has also closed below its 200 ema on a daily chart (which is generally considered bearish sign) I may be wrong here, but what i see is stock is nicely moving in flag formation on a weekly chart. It is consolidating for now. I will enter once that level breaks.
Here we have a low float stock that recently popped past the all time Resistance channel from back in 2016. Their is currently a massive order sitting to purchase 200k shares within the current price squeeze (triangle formation) Lots of good news about this stock recently. I like this setup and I personally think it will explode! Hodl
Very little to be found on this one fundamentally, as to what the catalyst could be. But SEC forms show numerous insiders (including CEO) buying before Christmas. Today, analyst Geulah Livshits from Chardan Capital released a buy rating with a PT of 33.